SEC Form 4 · accession 0001127602-17-016342
BIOGEN INC. · BIIB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michel Vounatsos
Officer — Chief Executive Officer · Director
Period of report
May 1, 2017
Accepted (ET)
May 2, 2017 · 4:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875045
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | May 1, 2017 | P | 1,402 | $271.35 | A | 2,927 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Purchase pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- F2Includes 91.527 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2017.